Guidelines are essential to improving clinical outcomes in breast cancer patients Alberto J. Montero Editorial 06 August 2015 Pages: 1 - 2
Post-irradiation angiosarcoma of the breast: clinical presentation and outcome in a series of six cases Anton UryvaevMor MoskovitzGeorgeta Fried Review 24 July 2015 Pages: 3 - 8
Localized experimental bone metastasis drives osteolysis and sensory hypersensitivity at distant non-tumor-bearing sites Dareen M. AbdelazizLaura S. StoneSvetlana V. Komarova Preclinical Study 25 July 2015 Pages: 9 - 20
Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer Parvin ForghaniEdmund K. Waller Preclinical study 25 July 2015 Pages: 21 - 30
Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer Elin KarlssonCynthia VeenstraOlle StĂĄl Preclinical Study 25 July 2015 Pages: 31 - 40
Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells Prathap Kumar S. MahalingaiahLogeswari PonnusamyKamaleshwar P. Singh Preclinical study 26 July 2015 Pages: 41 - 56
Heat shock factor 1 induces cancer stem cell phenotype in breast cancer cell lines Bin WangChung-Wei LeeTan A. Ince Preclinical study Open access 30 July 2015 Pages: 57 - 66
Assessment of HER2 status in invasive breast cancers with increased centromere 17 copy number Min Hye JangEun Joo KimSo Yeon Park Preclinical study 30 July 2015 Pages: 67 - 77
Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells Rahul R. DeshmukhQ. Ping Dou Preclinical Study 31 July 2015 Pages: 79 - 88
Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density G. L. ChewC. W. HuoE. W. Thompson Preclinical study 31 July 2015 Pages: 89 - 99
Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis Swapnil Ulhas RaneHasan MirzaSarah E. Pinder Preclinical study 09 August 2015 Pages: 101 - 121
A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity Xuejing YaoJing JiangJianmin Fang Preclinical Study 08 August 2015 Pages: 123 - 133
Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy Amadeo M. ParissentiBaoqing GuoMaureen E. Trudeau Clinical trial 25 July 2015 Pages: 135 - 144
The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure M. JebbinkE. van WerkhovenS. Rodenhuis Clinical trial 26 July 2015 Pages: 145 - 152
A proposal for a new classification of T4 breast cancer as stage IIIC: a report from the Korean Breast Cancer Society Hee Jeong KimHwa Jung KimKorean Breast Cancer Society Clinical trial 30 July 2015 Pages: 153 - 160
All eyes on the patient: the influence of oncologists’ nonverbal communication on breast cancer patients’ trust Marij A. HillenHanneke C. J. M. de HaesEllen M. A. Smets Clinical trial Open access 31 July 2015 Pages: 161 - 171
Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer A. Jo ChienErin DuraldeMitch P. Rosen Epidemiology 25 July 2015 Pages: 173 - 181
Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes Robert W. MutterMarlene H. FrostJudy C. Boughey Epidemiology 26 July 2015 Pages: 183 - 190
Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing Megan C. RobertsMorris WeinbergerStephanie B. Wheeler Epidemiology 28 July 2015 Pages: 191 - 200
Deleterious BRCA1/2 mutations in an urban population of Black women Filipa LynceKaren Lisa SmithClaudine Isaacs Epidemiology 07 August 2015 Pages: 201 - 209
Breast cancer survival in African-American women by hormone receptor subtypes Tomi AkinyemijuJustin Xavier MooreSean F. Altekruse Epidemiology 07 August 2015 Pages: 211 - 218
Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype Kuo-Wang TsaiGuan-Cheng LiHong-Tai Chang Epidemiology 08 August 2015 Pages: 219 - 234
